Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys

Journal of Bone and Mineral Research

Volumn 16, Issue 1, 2001, Pages 157-165

  Burr, David B ^a,b   Hirano, Toru ^a,b   Turner, Charles H ^a,b,c   Hotchkiss, Charlotte ^d   Brommage, Robert ^d   Hock, Janet M ^e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Indiana University Purdue University Indianapolis   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

Biomechanics; Cortical bone; Osteoporosis; Parathyroid hormone(1 34); Porosity

Indexed keywords

PARATHYROID HORMONE[1-34]; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MINERAL; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; FEMALE; HORMONAL THERAPY; HUMERUS; HYPERPARATHYROIDISM; MONKEY; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; POROSITY; TREATMENT OUTCOME;

ANIMALS; BODY WEIGHT; BONE DENSITY; BONE REMODELING; FEMALE; HUMERUS; INJECTIONS, SUBCUTANEOUS; MACACA FASCICULARIS; OVARIECTOMY; POROSITY; TENSILE STRENGTH; TERIPARATIDE;

EID: 0035158179     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.1.157     Document Type: Article

References (34)

1. The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1-34)
2. Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol
3. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial
4. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: The influence of human parathyroid fragment (hPTH 1-34) therapy
5. The ferret as a small animal model with BMU-based remodeling for skeletal research
6. Effect of treatment for 3 months with human parathyroid hormone 1-34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis)
7. Bone changes with long-term administration of low doses of 1-34 human PTH in adult beagles
8. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone
9. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate - Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
10. Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles
11. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34) LY33334, on remodeling and mechanical properties of cortical bone in rabbits
12. Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (HPTH 1-34)
13. Measurement of Haversian bone remodeling by means of tetracycline labelling in rib of rhesus monkeys
14. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone vs. cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis
15. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone (1-34)
16. Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
17. Daily treatment with human recombinant parathyroid hormone 1-34 for one year increases bone mass in ovariectomized monkeys
18. Bone histomorphometry: Standardization of nomenclature, symbols, and units
19. The compressive behavior of bone as a two-phase porous structure
20. Basic biomechanical measurements of bone: A tutorial
21. Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients
22. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats
23. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum
24. Human parathyroid hormone (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats
25. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats
26. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats
27. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model
28. Bisphosphonate maintains parathyroid hormone (1-34)-induced cortical bone mass and mechanical strength in old rats
29. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats
30. Quantitative analysis of trabecular bone in ovariectomized rats after intermittent administration of low dose human parathyroid hormone fragment (1-34) and 17β-estradiol
31. Loss of the anabolic effect of PTH on bone after discontinuation of hormone in rats
32. Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH (1-34) administration
33. Dose effect of parathyroid hormone (1-84) on bone formation and porosity in cortical bone of rhesus monkeys
34. Cortical bone remodeling in femur and radius is stimulated by parathyroid hormone treatment in ovariectomized female cynomolgus macaques